Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.
复制标题
DOI：
10.1002/advs.202305662
复制
发表时间：
2024-01
期刊：
影响因子：
--
通讯作者：
Wang Z
中科院分区：
文献类型：
--
作者：
Cheng Q;Shi XL;Li QL;Wang L;Wang Z
Increasing numbers of studies have shown that tumor cells prefer fermentative glycolysis over oxidative phosphorylation to provide a vast amount of energy for fast proliferation even under oxygen‐sufficient conditions. This metabolic alteration not only favors tumor cell progression and metastasis but also increases lactate accumulation in solid tumors. In addition to serving as a byproduct of glycolytic tumor cells, lactate also plays a central role in the construction of acidic and immunosuppressive tumor microenvironment, resulting in therapeutic tolerance. Recently, targeted drug delivery and inherent therapeutic properties of nanomaterials have attracted great attention, and research on modulating lactate metabolism based on nanomaterials to enhance antitumor therapy has exploded. In this review, the advanced tumor therapy strategies based on nanomaterials that interfere with lactate metabolism are discussed, including inhibiting lactate anabolism, promoting lactate catabolism, and disrupting the “lactate shuttle”. Furthermore, recent advances in combining lactate metabolism modulation with other therapies, including chemotherapy, immunotherapy, photothermal therapy, and reactive oxygen species‐related therapies, etc., which have achieved cooperatively enhanced therapeutic outcomes, are summarized. Finally, foreseeable challenges and prospective developments are also reviewed for the future development of this field. Lactate has long been overlooked in tumors, confined to the roles of a glycolysis waste product and a biomarker of malignancy. With in‐depth research, lactate has recently been recognized as an important factor in tumor progression, metastasis, and therapeutic resistance. This review comprehensively summarizes the recent progress in nanomaterial‐mediated lactate metabolism modulation for oncotherapy.
登录
查看更多内容
影响因子：
16.6
作者：
Chen, Qi-Wen;Wang, Jia-Wei;Zhang, Xian-Zheng
通讯作者：
Zhang, Xian-Zheng
影响因子：
19
作者：
Chen, Zhao-Xia;Liu, Miao-Deng;Zhang, Xian-Zheng
通讯作者：
Zhang, Xian-Zheng
影响因子：
14
作者：
Dai, Yeneng;Sun, Zhiquan;Huang, Wei
通讯作者：
Huang, Wei
影响因子：
4.6
作者：
Cheng G;Hardy M;You M;Kalyanaraman B
通讯作者：
Kalyanaraman B
影响因子：
17.1
作者：
An, Jingyi;Zhang, Kaixiang;Shi, Jinjin
通讯作者：
Shi, Jinjin